336040 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
TASCOM Co., Ltd. engages in the research and development of cell therapy treatment for diabetes and in the supply and distribution of diabetic medical devices. Its products include blood sugar measurement system, pen needles, insulin syringe, sharps containers, safety lancets and others. The company was founded on March 11, 2014 and is headquartered in Anyang-si, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
336040 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company